NCT04409314
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +33 more
- Locations
-
- University of California, San Francisco San Francisco, California, United States
Clinical trial condition
Refractory Plasma Cell Myeloma
Explore clinical trials studying Refractory Plasma Cell Myeloma. Study availability and eligibility vary by location and protocol.
55 public trials
4 recruiting studies
Refractory Plasma Cell Myeloma trial results
NCT02514382
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
- Locations
-
- USC / Norris Comprehensive Cancer Center Los Angeles, California, United States
NCT01989598
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
- Locations
-
- Foothills Hospital Calgary, Alberta, Canada
- Tom Baker Cancer Centre Calgary, Alberta, Canada
- Cross Cancer Institute Edmonton, Alberta, Canada
- Kingston Health Sciences Centre Kingston, Ontario, Canada
Completed
Sonidegib and Lenalidomide After Stem Cell Transplant in Treating Patients With Multiple Myeloma
NCT02086552
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
- Locations
-
- Mayo Clinic Rochester, Minnesota, United States
NCT04439240
- Conditions
- Advanced Lymphoma, Advanced Malignant Solid Neoplasm, Blood Protein Disorders, +22 more
- Locations
-
- ECOG-ACRIN Cancer Research Group Philadelphia, Pennsylvania, United States
NCT04439214
- Conditions
- Advanced Lymphoma, Advanced Malignant Solid Neoplasm, Blood Protein Disorders, +23 more
- Locations
-
- ECOG-ACRIN Cancer Research Group Philadelphia, Pennsylvania, United States
NCT02948283
- Conditions
- Anemia, Blood Platelet Disorders, Blood Protein Disorders, +44 more
- Locations
-
- City of Hope Medical Center Duarte, California, United States
NCT02095834
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
NCT00966693
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
Completed
Carfilzomib and Melphalan Before Stem Cell Transplant in Treating Patients With Multiple Myeloma
NCT01842308
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, DS Stage I Plasma Cell Myeloma, +16 more
- Locations
-
- Mayo Clinic in Florida Jacksonville, Florida, United States
- Mayo Clinic Rochester, Minnesota, United States